孕前的试验改变了实践
Eniola R Ibirogba1, Jennifer Grasch1, Maged M Costantine1
1Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, The Ohio State University, United States.
孕前严重危害母亲和新生儿. 本综述强调了阿司匹林,他类药物和高血压治疗作为产前的主要预防和管理策略.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 心血管研究研究心血管研究
背景情况:
- 妊娠的高血压疾病,特别是产前,是导致不良孕产妇,胎儿和新生儿后果的主要原因.
- 有效的预防和管理策略对于减轻这些风险至关重要.
研究的目的:
- 审查关键的临床和转化研究,这些研究为预防和治疗先兆子提供了信息.
- 综合有关管理策略的现有证据,并确定未来研究的领域.
主要方法:
- 临床和翻译研究的综合文献综述.
- 临床前试验,随机对照试验和临床研究的分析.
- 综合有关药理干预和递送时间的证据.
主要成果:
- 低剂量阿司匹林是一种标准的预防策略;他类药物显示出新兴的潜力.
- 治疗轻度慢性高血压可以降低孕前的风险和并发症.
- 硫酸用于发作预防和最佳分娩时间是基于证据的管理方面.
结论:
- 目前的研究已经建立了孕前的基本预防和治疗策略.
- 进一步研究新型治疗点和改进的治疗方法至关重要,以减少孕前的持续负担.
更多相关视频
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
12:17The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
相关概念视频
Clinical Trials
There are four phases in a clinical trial. A phase one...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Clinical Trials: Overview
Hypertension V: Nursing Management
Pre-Procedural Guidelines for Assessing Blood Pressure
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
